Morgan Stanley’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.23M Sell
2,020,108
-1,921,269
-49% -$7.64M ﹤0.01% 3852
2025
Q4
$13.8M Buy
3,941,377
+294,338
+8% +$1.01M ﹤0.01% 3293
2025
Q3
$11.9M Buy
3,647,039
+478,003
+15% +$1.51M ﹤0.01% 3388
2025
Q2
$7.76M Buy
3,169,036
+527,144
+20% +$2.67M ﹤0.01% 3686
2025
Q1
$17.6M Buy
2,641,892
+1,457,183
+123% +$14.4M ﹤0.01% 2818
2024
Q4
$14.9M Buy
1,184,709
+569,181
+92% +$8.57M ﹤0.01% 3037
2024
Q3
$11.4M Buy
615,528
+139,540
+29% +$2.86M ﹤0.01% 3332
2024
Q2
$10.2M Sell
475,988
-212,825
-31% -$4.89M ﹤0.01% 3308
2024
Q1
$18.6M Sell
688,813
-535,133
-44% -$15.2M ﹤0.01% 2779
2023
Q4
$36.7M Buy
1,223,946
+445,195
+57% +$9.83M ﹤0.01% 2777
2023
Q3
$16M Buy
778,751
+276,627
+55% +$5.03M ﹤0.01% 2687
2023
Q2
$9.98M Sell
502,124
-89,902
-15% -$1.82M ﹤0.01% 3165
2023
Q1
$10.1M Buy
592,026
+57,674
+11% +$1.13M ﹤0.01% 3127
2022
Q4
$10.5M Sell
534,352
-661,733
-55% -$12.2M ﹤0.01% 3043
2022
Q3
$19.1M Sell
1,196,085
-86,914
-7% -$1.36M ﹤0.01% 2237
2022
Q2
$17.7M Sell
1,282,999
-203,689
-14% -$2.43M ﹤0.01% 2433
2022
Q1
$23.6M Buy
1,486,688
+286,807
+24% +$4.95M ﹤0.01% 1939
2021
Q4
$26.2M Buy
1,199,881
+1,036,981
+637% +$28.3M ﹤0.01% 1880
2021
Q3
$4.87M Buy
162,900
+60,501
+59% +$2.2M ﹤0.01% 3737
2021
Q2
$4.54M Sell
102,399
-28,627
-22% -$1.24M ﹤0.01% 3883
2021
Q1
$5.82M Sell
131,026
-84,987
-39% -$4.67M ﹤0.01% 3251
2020
Q4
$11.8M Sell
216,013
-228,171
-51% -$8.32M ﹤0.01% 2326
2020
Q3
$10.2M Sell
444,184
-80,420
-15% -$1.98M ﹤0.01% 2014
2020
Q2
$11M Sell
524,604
-235,839
-31% -$4.25M ﹤0.01% 1887
2020
Q1
$10.6M Sell
760,443
-279,047
-27% -$5.53M ﹤0.01% 1720
2019
Q4
$23.7M Buy
1,039,490
+327,537
+46% +$5.47M 0.01% 1518
2019
Q3
$8.29M Buy
711,953
+18,299
+3% +$227K ﹤0.01% 2316
2019
Q2
$10.4M Sell
693,654
-108,081
-13% -$1.89M ﹤0.01% 2112
2019
Q1
$14.1M Buy
801,735
+258,931
+48% +$4.09M ﹤0.01% 1722
2018
Q4
$8.04M Sell
542,804
-165,371
-23% -$2.75M ﹤0.01% 2358
2018
Q3
$17.4M Buy
708,175
+540,942
+323% +$11.7M ﹤0.01% 1821
2018
Q2
$3.28M Buy
167,233
+148,961
+815% +$2.82M ﹤0.01% 3611
2018
Q1
$343K Buy
18,272
+17,022
+1,362% +$278K ﹤0.01% 5211
2017
Q4
$13K Sell
1,250
-9,125
-88% -$90.5K ﹤0.01% 6178
2017
Q3
$74K Sell
10,375
-8,501
-45% -$38.9K ﹤0.01% 5660
2017
Q2
$144K Buy
18,876
+2,018
+12% +$15K ﹤0.01% 5489
2017
Q1
$135K Buy
16,858
+1,953
+13% +$13.1K ﹤0.01% 5493
2016
Q4
$363K Buy
14,905
+10,861
+269% +$310K ﹤0.01% 5099
2016
Q3
$153K Buy
4,044
+1,325
+49% +$41.7K ﹤0.01% 5122
2016
Q2
$81K Sell
2,719
-17,194
-86% -$605K ﹤0.01% 5335
2016
Q1
$590K Buy
19,913
+16,188
+435% +$486K ﹤0.01% 4319
2015
Q4
$169K Buy
3,725
+2,196
+144% +$95.7K ﹤0.01% 5168
2015
Q3
$57K Buy
1,529
+1,279
+512% +$58.7K ﹤0.01% 5679
2015
Q2
$5K Sell
250
-4,265
-94% -$94.4K ﹤0.01% 6417
2015
Q1
$97K Buy
+4,515
New +$106K ﹤0.01% 5544

Other funds holding RCKT